Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muntner, P.
Right arrow Articles by Whelton, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muntner, P.
Right arrow Articles by Whelton, P. K.
J Am Soc Nephrol 13:745-753, 2002
© 2002 American Society of Nephrology

Renal Insufficiency and Subsequent Death Resulting from Cardiovascular Disease in the United States

Paul Muntner*, Jiang He*{dagger}, Lee Hamm{dagger}, Catherine Loria{ddagger} and Paul K. Whelton*{dagger}

*Department of Epidemiology, School of Public Health and Tropical Medicine, and {dagger}Department of Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, and {ddagger}National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Correspondence to Dr. Paul Muntner, Department of Epidemiology, Tulane University SPHTM, 1430 Tulane Avenue, SL-18, New Orleans, LA 70112. Phone: 504-988-1047; Fax: 504-988-1568; E-mail: pmuntner{at}tulane.edu

ABSTRACT. Several epidemiologic studies reported that persons with renal insufficiency might have increased cardiovascular disease-related mortality rates in select populations. The association between renal insufficiency and increased cardiovascular disease-related and all-cause mortality rates during 16 yr of follow-up monitoring was examined among participants who were 30 to 74 yr of age at the baseline examinations in 1976 to 1980, with urinary protein dipstick measurements (n = 8786) or serum creatinine levels of <=3.0 mg/dl (n = 6354), from the Second National Health and Nutrition Examination Survey Mortality Study. GFR were estimated by adjusting serum creatinine levels for age, race, and gender, using the Modification of Diet in Renal Disease formula. Cardiovascular disease-related mortality rates were 6.2, 17.9, and 37.2 deaths/1000 person-yr among subjects with urinary protein levels of <30, 30 to 299, and >=300 mg/dl and were 4.1, 8.6, and 20.5 deaths/1000 person-yr among participants with estimated GFR of >=90, 70 to 89, and <70 ml/min, respectively. After adjustment for potential confounders, the relative hazards (and 95% confidence intervals) for cardiovascular disease-related death were 1.57 (0.99 to 2.48) and 1.77 (0.97 to 3.21) among subjects with urinary protein levels of 30 to 299 and >=300 mg/dl, respectively, compared with <30 mg/dl (P trend = 0.02). The corresponding relative hazards for all-cause-related death were 1.64 (1.23 to 2.18) and 2.00 (1.13 to 3.55; P trend < 0.001). Compared with subjects with estimated GFR of >=90 ml/min, those with estimated GFR of <70 ml/min exhibited higher relative risks of death from cardiovascular disease and all causes [1.68 (1.33 to 2.13) and 1.51 (1.19 to 1.91), respectively]. This study indicates that, in a representative sample of the United States general population, renal insufficiency is independently associated with increased cardiovascular disease-related and all-cause mortality rates.




This article has been cited by other articles:


Home page
 ICVTSHome page
J. Silva, N. Ridao-Cano, A. Segura, L. C. Maroto, J. Cobiella, M. Carnero, A. Barrientos, and J. E. Rodriguez
Can estimated glomerular filtration rate improve the EuroSCORE?
Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1054 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Cottone, G. Mule, M. Guarneri, A. Palermo, M. C. Lorito, R. Riccobene, R. Arsena, F. Vaccaro, A. Vadala, E. Nardi, et al.
Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients
Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn489v1.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Chonchol, H. Gnahn, and D. Sander
Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly
Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2593 - 2598.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Nerpin, U. Riserus, E. Ingelsson, J. Sundstrom, M. Jobs, A. Larsson, S. Basu, and J. Arnlov
Insulin Sensitivity Measured With Euglycemic Clamp Is Independently Associated With Glomerular Filtration Rate in a Community-Based Cohort
Diabetes Care, August 1, 2008; 31(8): 1550 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. Hsu, K. L. Johansen, C.-y. Hsu, G. A. Kaysen, and G. M. Chertow
Higher Serum Creatinine Concentrations in Black Patients with Chronic Kidney Disease: Beyond Nutritional Status and Body Composition
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 992 - 997.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr.
Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. Mehrotra, D. Kermah, L. Fried, S. Adler, and K. Norris
Racial Differences in Mortality Among Those with CKD
J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1403 - 1410.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Chonchol, M. Cigolini, and G. Targher
Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 269 - 274.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. S. DeLoach and R. R. Townsend
Vascular Stiffness: Its Measurement and Significance for Epidemiologic and Outcome Studies
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 184 - 192.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
S. R. Orth and S. I. Hallan
Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. L. Smith, F. A. Masoudi, M. G. Shlipak, H. M. Krumholz, and C. R. Parikh
Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction
J. Am. Soc. Nephrol., January 1, 2008; 19(1): 141 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. T. Raymond, D. Zehnder, S. C. H. Smith, J. A. Stinson, H. Lehnert, and R. M. Higgins
Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3214 - 3220.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Sheehan, S.-W. Tsaih, B. L. King, C. Stanton, G. A. Churchill, B. Paigen, and K. DiPetrillo
Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1649 - F1656.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
L. G. Glynn, D. Reddan, J. Newell, J. Hinde, B. Buckley, and A. W. Murphy
Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2586 - 2594.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
A. Rashidi, A. Ghanbarian, and F. Azizi
Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 976 - 983.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. N. Foley, C. Wang, A. Ishani, and A. J. Collins
NHANES III: Influence of Race on GFR Thresholds and Detection of Metabolic Abnormalities
J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2575 - 2582.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al.
Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease
Ann Intern Med, July 3, 2007; 147(1): 19 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Nakayama, H. Metoki, H. Terawaki, T. Ohkubo, M. Kikuya, T. Sato, K. Nakayama, K. Asayama, R. Inoue, J. Hashimoto, et al.
Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study
Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1910 - 1915.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
P. W. B. Nanayakkara, C. van Guldener, P. M. ter Wee, P. G. Scheffer, F. J. van Ittersum, J. W. Twisk, T. Teerlink, W. van Dorp, and C. D. A. Stehouwer
Effect of a Treatment Strategy Consisting of Pravastatin, Vitamin E, and Homocysteine Lowering on Carotid Intima-Media Thickness, Endothelial Function, and Renal Function in Patients With Mild to Moderate Chronic Kidney Disease: Results From the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study
Arch Intern Med, June 25, 2007; 167(12): 1262 - 1270.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H. D. White, E. Braunwald, S. A. Murphy, A. J. Jacob, N. Gotcheva, L. Polonetsky, and E. M. Antman
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25
Eur. Heart J., May 1, 2007; 28(9): 1066 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Chen, D. Gu, C.-S. Chen, X. Wu, L. L. Hamm, P. Muntner, V. Batuman, C.-H. Lee, P. K. Whelton, and J. He
Association between the metabolic syndrome and chronic kidney disease in Chinese adults
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1100 - 1106.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Wattanakit, A. R. Folsom, E. Selvin, J. Coresh, A. T. Hirsch, and B. D. Weatherley
Kidney Function and Risk of Peripheral Arterial Disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 629 - 636.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. Mathew, R. J. Lund, F. Strebeck, K. S. Tustison, T. Geurs, and K. A. Hruska
Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 122 - 130.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. G. Wannamethee, A. G. Shaper, G. D.O. Lowe, L. Lennon, A. Rumley, and P. H. Whincup
Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers
Eur. Heart J., December 2, 2006; 27(24): 2975 - 2981.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend
The treatment of coronary artery disease in patients with chronic kidney disease
QJM, November 1, 2006; 99(11): 723 - 736.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. C. Norris, T. Greene, J. Kopple, J. Lea, J. Lewis, M. Lipkowitz, P. Miller, A. Richardson, S. Rostand, X. Wang, et al.
Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2928 - 2936.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Schillaci, M. Pirro, M. R. Mannarino, G. Pucci, G. Savarese, S. S. Franklin, and E. Mannarino
Relation Between Renal Function Within the Normal Range and Central and Peripheral Arterial Stiffness in Hypertension
Hypertension, October 1, 2006; 48(4): 616 - 621.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
K. Wattanakit, J. Coresh, P. Muntner, J. Marsh, and A. R. Folsom
Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1183 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
C. Tomiyama, A. Higa, M. A. Dalboni, M. Cendoroglo, S. A. Draibe, L. Cuppari, A. B. Carvalho, E. M. Neto, and M. E. F. Canziani
The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2464 - 2471.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. A. Sarafidis and G. L. Bakris
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Zhang, L. Zuo, F. Wang, M. Wang, S. Wang, J. Lv, L. Liu, and H. Wang
Cardiovascular Disease in Early Stages of Chronic Kidney Disease in a Chinese Population
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2617 - 2621.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
N. Volkova, W. McClellan, J. M. Soucie, and A. Schoolwerth
Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2202 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. D. Monk and D. A. Bennett
Reno-cerebrovascular disease? The incognito kidney in cognition and stroke.
Neurology, July 25, 2006; 67(2): 196 - 198.
[Full Text] [PDF]

Home page
 CJASNHome page
E. S. Ommen, J. A. Winston, and B. Murphy
Medical Risks in Living Kidney Donors: Absence of Proof Is Not Proof of Absence
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 885 - 895.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, M. Fok, F. McAlister, and A. X. Garg
Chronic Kidney Disease and Mortality Risk: A Systematic Review
J. Am. Soc. Nephrol., July 1, 2006; 17(7): 2034 - 2047.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
H. T. Nguyen and A. G. Stack
Ethnic Disparities in Cardiovascular Risk Factors and Coronary Disease Prevalence among Individuals with Chronic Kidney Disease: Findings from the Third National Health and Nutrition Examination Survey
J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1716 - 1723.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
B. R. Hemmelgarn, D. A. Southern, K. H. Humphries, B. F. Culleton, M. L. Knudtson, W. A. Ghali, and for the Alberta Provincial Project for Outcomes As
Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization
Eur. Heart J., May 2, 2006; 27(10): 1191 - 1197.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C. Meisinger, A. Doring, H. Lowel, and for the KORA Study Group
Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population
Eur. Heart J., May 2, 2006; 27(10): 1245 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
K. Iseki
Screening for renal disease--what can be learned from the Okinawa experience
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 839 - 843.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Yamamoto and Y. Aso
Synergistic Association of Metabolic Syndrome and Overt Nephropathy With Elevated Asymmetric Dimethylarginine in Serum and Impaired Cutaneous Microvasodilation in Patients With Type 2 Diabetes
Diabetes Care, April 1, 2006; 29(4): 928 - 930.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
G. D'Amico
Statins and Renal Diseases: From Primary Prevention to Renal Replacement Therapy.
J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S148 - S152.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. M. O'Hare, D. Bertenthal, K. E. Covinsky, C. S. Landefeld, S. Sen, K. Mehta, M. A. Steinman, A. Borzecki, and L. C. Walter
Mortality Risk Stratification in Chronic Kidney Disease: One Size for All Ages?
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 846 - 853.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. A. Sarafidis and G. L. Bakris
Level of Kidney Function Determines Cardiovascular Fate After Coronary Bypass Graft Surgery
Circulation, February 28, 2006; 113(8): 1046 - 1047.
[Full Text] [PDF]

Home page
 CirculationHome page
G. S. Hillis, B. L. Croal, K. G. Buchan, H. El-Shafei, G. Gibson, R. R. Jeffrey, C. G.M. Millar, G. J. Prescott, and B. H. Cuthbertson
Renal Function and Outcome From Coronary Artery Bypass Grafting: Impact on Mortality After a 2.3-Year Follow-Up
Circulation, February 28, 2006; 113(8): 1056 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Rahman, S. Pressel, B. R. Davis, C. Nwachuku, J. T. Wright Jr., P. K. Whelton, J. Barzilay, V. Batuman, J. H. Eckfeldt, M. A. Farber, et al.
Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate
Ann Intern Med, February 7, 2006; 144(3): 172 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. De Cosmo, R. Trevisan, A. Minenna, M. Vedovato, R. Viti, S. A. Santini, A. R. Dodesini, P. Fioretto, and V. Trischitta
Insulin Resistance and the Cluster of Abnormalities Related to the Metabolic Syndrome Are Associated With Reduced Glomerular Filtration Rate in Patients With Type 2 Diabetes
Diabetes Care, February 1, 2006; 29(2): 432 - 434.
[Full Text] [PDF]

Home page
 QJMHome page
Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, A. Cohen, and J. Stessman
Moderate renal insufficiency at 70 years predicts mortality
QJM, February 1, 2006; 99(2): 97 - 102.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. R. Leeder, P. Mitchell, G. Liew, E. Rochtchina, W. Smith, and J. J. Wang
Low Hemoglobin, Chronic Kidney Disease, and Risk for Coronary Heart Disease-Related Death: The Blue Mountains Eye Study
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 279 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. H. Jee, L. E. Boulware, E. Guallar, I. Suh, L. J. Appel, and E. R. Miller III
Direct, Progressive Association of Cardiovascular Risk Factors With Incident Proteinuria: Results From the Korea Medical Insurance Corporation (KMIC) Study
Arch Intern Med, October 24, 2005; 165(19): 2299 - 2304.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. N. Reddan, L. Szczech, M. V. Bhapkar, D. J. Moliterno, R. M. Califf, E. M. Ohman, P. B. Berger, J. S. Hochman, F. Van de Werf, R. A. Harrington, et al.
Renal function, concomitant medication use and outcomes following acute coronary syndromes
Nephrol. Dial. Transplant., October 1, 2005; 20(10): 2105 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
P. Gil, S. Justo, and C. Caramelo
Cardio-renal failure: an emerging clinical entity
Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1780 - 1783.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. M. O'Hare, R. A. Rodriguez, and P. Bacchetti
Low Ankle-Brachial Index Associated With Rise in Creatinine Level Over Time: Results From the Atherosclerosis Risk in Communities Study
Arch Intern Med, July 11, 2005; 165(13): 1481 - 1485.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox)
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. E. Weiner, H. Tighiouart, P. T. Vlagopoulos, J. L. Griffith, D. N. Salem, A. S. Levey, and M. J. Sarnak
Effects of Anemia and Left Ventricular Hypertrophy on Cardiovascular Disease in Patients with Chronic Kidney Disease
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1803 - 1810.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. R. Davies, Richard. J. Lund, S. Mathew, and K. A. Hruska
Low Turnover Osteodystrophy and Vascular Calcification Are Amenable to Skeletal Anabolism in an Animal Model of Chronic Kidney Disease and the Metabolic Syndrome
J. Am. Soc. Nephrol., April 1, 2005; 16(4): 917 - 928.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. N. Foley, A. M. Murray, S. Li, C. A. Herzog, A. M. McBean, P. W. Eggers, and A. J. Collins
Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 489 - 495.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. Muntner, J. He, B. C. Astor, A. R. Folsom, and J. Coresh
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease: Results from the Atherosclerosis Risk in Communities Study
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 529 - 538.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam
The severe cardiorenal syndrome: 'Guyton revisited'
Eur. Heart J., January 1, 2005; 26(1): 11 - 17.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. Jernberg, B. Lindahl, S. James, A. Larsson, L.-O. Hansson, and L. Wallentin
Cystatin C: A Novel Predictor of Outcome in Suspected or Confirmed Non-ST-Elevation Acute Coronary Syndrome
Circulation, October 19, 2004; 110(16): 2342 - 2348.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. S. Go, G. M. Cher